<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03614598</url>
  </required_header>
  <id_info>
    <org_study_id>Local/2008/JL- 02</org_study_id>
    <nct_id>NCT03614598</nct_id>
  </id_info>
  <brief_title>Impact on Postoperative Pain of Three Single-use Adult Supraglottic Airway Devices in Short General Anesthetic Under Controlled Ventilation</brief_title>
  <acronym>DISPOSITIF LAR</acronym>
  <official_title>Impact on Postoperative Pain of Three Single-use Adult Supraglottic Airway Devices in Short General Anesthetic Under Controlled Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that incidence of pharyngolaryngeal postoperative pain caused
      by the I-gel and LMA-Suprême devices will be ≤ 5%
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 22, 2009</start_date>
  <completion_date type="Actual">September 5, 2012</completion_date>
  <primary_completion_date type="Actual">September 5, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of pharyngolaryngeal postoperative pain of the three devices</measure>
    <time_frame>24 hours</time_frame>
    <description>Sore throat Y/N</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pharyngolaryngeal postoperative pain between groups</measure>
    <time_frame>2 hours</time_frame>
    <description>Sore throat Y/N</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time taken to place device</measure>
    <time_frame>End of surgery (maximum 2 hours)</time_frame>
    <description>From first attempt at introduction until acceptable exhaled CO2 curve attained (seconds)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of attempts needed to place device</measure>
    <time_frame>End of surgery (maximum 2 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necessity of altering the size of the device</measure>
    <time_frame>End of surgery (maximum 2 hours)</time_frame>
    <description>Y/N</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any patient movement during procedure</measure>
    <time_frame>End of surgery (maximum 2 hours)</time_frame>
    <description>Y/N</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficulty of insertion</measure>
    <time_frame>End of surgery (maximum 2 hours)</time_frame>
    <description>5-point scale: very easy-failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total leakage pressure of the devices</measure>
    <time_frame>End of surgery (maximum 2 hours)</time_frame>
    <description>measured directly by the respirator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilatory pressure of the devices</measure>
    <time_frame>End of surgery (maximum 2 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device stability during surgery</measure>
    <time_frame>End of surgery (maximum 2 hours)</time_frame>
    <description>Need to change the management system airways (orotracheal intubation or others) Y/N</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficulty of device removal</measure>
    <time_frame>End of surgery (maximum 2 hours)</time_frame>
    <description>4-point scale: very easy-very difficult</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">546</enrollment>
  <condition>Pharyngolaryngeal Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>LMA-UNIQUE™</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>LMA-SUPREME™</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>I-GEL®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Insertion of LMA-UNIQUE(TM) device</intervention_name>
    <description>LMA-UNIQUE(TM) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation</description>
    <arm_group_label>LMA-UNIQUE™</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Insertion of LMA-SUPREME(TM) device</intervention_name>
    <description>LMA-SUPREME(TM) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation</description>
    <arm_group_label>LMA-SUPREME™</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Insertion of I-GEL(R) device</intervention_name>
    <description>I-GEL(R) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation</description>
    <arm_group_label>I-GEL®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must have given their free and informed consent and signed the consent
             form

          -  The patient must be a member or beneficiary of a health insurance plan

          -  Adult patients &gt; 18

          -  ASA score I-III

          -  Patient scheduled to undergo elective surgery lasting less than two hours under
             general anaesthetic without tracheal intubation

          -  The subject is participating in an interventional study, or is in a period of
             exclusion determined by a previous study

          -  The subject refuses to sign the consent

          -  It is impossible to give the subject informed information

          -  The patient is under safeguard of justice or state guardianship

          -  The patient is pregnant or breastfeeding

          -  Emergency surgery

          -  Sore thoat ≤ 1 month

          -  Risk of aspiration of gastric contents

          -  Body mass index (BMI) &gt; 35

          -  Patients with expected airway difficulties

          -  Contra-indication for any of the devices (symptomatic hiatal hernias, pathological
             obesity, poly trauma or serious injury, delayed gastric emptying, use of opiates
             during fasting)

          -  Patients who are not fasting for routine and emergency anesthesia

          -  Trismus, limited mouth opening, abscess or pharyngoperilaryngeal mass
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joël L'Hermite, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nimes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Nimes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 20, 2018</study_first_submitted>
  <study_first_submitted_qc>July 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2018</study_first_posted>
  <last_update_submitted>July 30, 2018</last_update_submitted>
  <last_update_submitted_qc>July 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

